NRx Pharmaceuticals Inc. (NRXPW) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NRx Pharmaceuticals Inc.

    NASDAQ: NRXPW · Real-Time Price · USD
    0.10
    0.01 (11.11%)
    At close: Jun 09, 2025, 3:41 PM

    NRx Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.92 -1.16 -20.72 -31.27
    PEG Ratio
    		 0.02 -0.00 0.32 -0.1
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 -1 -2.97 98.53 107.79
    P/FCF Ratio
    		 -2.18 -1.61 -18.36 -59.47
    P/OCF Ratio
    		 -2.18 -1.61 -18.36 -59.48
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 -0.28 -0.78 1.42 0.02
    Quick Ratio
    		 0.15 0.36 1.56 2.74
    Current Ratio
    		 0.15 0.36 1.56 2.74
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 -80.44 -229.89 n/a -6.43K
    Return on Equity
    		 1.08 2.57 -4.76 -3.45
    Return on Assets
    		 -6.88 -4.12 -1.36 -2.19
    Return on Invested Capital
    		 1.11 10.72 -2.32 -4.18
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist